More recently, the European Society of Cardiology (ESC) has deemed GLP-1 RAs to be the first-line therapy for cardiovascular risk reduction in patients with T2DM with very high/high risk [10]
This foundational science underpins all translational efforts, generating insights that enable new medicines and innovations worldwide.
Eli Lilly , with its dual-action tirzepatide (sold as Mounjaro for diabetes and Zepbound for obesity), is not far behind
FAQs About Weight Loss Injections Both are highly effective, but tirzepatide has shown slightly greater average weight loss in clinical studies
Matt Brown, Chief Scientific Officer at Genomics England, UK, echoed this, stating that the partnership reflects a wider move toward a prevention-first model of healthcare, underpinned by genomic data
Over the past year, there has been an explosion in the popularity of GLP-1 receptor agonist drugs namely Ozempic and Wegovy , which are respectively used to treat diabetes and obesity